HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Sulkes Selected Research

Neoplasms (Cancer)

1/2006Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
5/2001Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer.
2/2001The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
9/2000Low PSA metastatic androgen- independent prostate cancer.
3/2000[High dose endobronchial brachytherapy for malignant airway obstruction: first study of 30 patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Sulkes Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
03/2009 - 04/2000
5Neoplasms (Cancer)
01/2006 - 03/2000
2Colorectal Neoplasms (Colorectal Cancer)
02/2002 - 08/2001
2Neoplasm Metastasis (Metastasis)
08/2001 - 09/2000
2Prostatic Neoplasms (Prostate Cancer)
09/2000 - 09/2000
1Dyspnea (Shortness of Breath)
03/2009
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2006
1Inflammatory Breast Neoplasms
12/2002
1Necrosis
05/2001
1Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2001
1Second Primary Neoplasms (Neoplasms, Second)
04/2001
1Dermatitis
03/2001
1Bone Diseases (Bone Disease)
09/2000
1Adenocarcinoma
09/2000
1Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2000
1Hodgkin Disease (Hodgkin's Disease)
05/2000
1Carcinoma (Carcinomatosis)
04/2000
1Medullary Carcinoma
04/2000
1Airway Obstruction (Choking)
03/2000
1Merkel Cell Carcinoma
02/2000

Drug/Important Bio-Agent (IBA)

2AndrogensIBA
09/2000 - 09/2000
1Hemoglobins (Hemoglobin)IBA
03/2009
1C-Reactive ProteinIBA
03/2009
1Carbon MonoxideIBA
03/2009
1Paclitaxel (Taxol)FDA LinkGeneric
03/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2003
1Fluorouracil (Carac)FDA LinkGeneric
02/2002
1Leucovorin (Folinic Acid)FDA Link
02/2002
1LipidermIBA
03/2001
1Ointments (Pastes)IBA
03/2001
1BiafineIBA
03/2001
1EnzymesIBA
02/2001
1Androgen Antagonists (Antiandrogens)IBA
09/2000
1Carcinoembryonic AntigenIBA
09/2000
1Eosine Yellowish-(YS) (Eosin)IBA
09/2000
1EstramustineFDA Link
09/2000
1Hematoxylin (Haematoxylon)IBA
09/2000
1Hormones (Hormone)IBA
09/2000
1Cisplatin (Platino)FDA LinkGeneric
09/2000
1Phosphopyruvate Hydratase (Enolase)IBA
09/2000
1Vinblastine (Vinblastine Sulfate)FDA Link
09/2000
1Chromogranin AIBA
09/2000
1HLA-DR Antigens (HLA-DR)IBA
04/2000
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
04/2000
1AntigensIBA
04/2000
1Etoposide (VP 16)FDA LinkGeneric
02/2000
1Pharmaceutical PreparationsIBA
02/2000
1Topoisomerase II InhibitorsIBA
02/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
03/2009 - 09/2000
4Radiotherapy
01/2006 - 05/2000
2Segmental Mastectomy (Lumpectomy)
01/2006 - 12/2002
2Combination Drug Therapy (Combination Chemotherapy)
08/2001 - 09/2000
1AC protocol (CA protocol)
03/2009
1Conservative Treatment
01/2006
1Consolidation Chemotherapy
04/2003
1Stem Cell Transplantation
04/2003
1Induction Chemotherapy
12/2002
1Aftercare (After-Treatment)
04/2001
1Prophylactic Mastectomy
05/2000
1Immunotherapy
04/2000
1Catheters
03/2000
1Brachytherapy
03/2000
1Palliative Care (Palliative Therapy)
03/2000
1Bronchoscopes
03/2000